Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201307003 Principal Investigator: Cashen, Amanda
Title: Phase 1 Dose Finding Study of Belinostat plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone (CHOP) Regimen (BelCHOP) for Treatment of Patients with Peripheral T-cell Lymphoma (PTCL)
Phase: I Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purposes of this study are: Part A (dose escalation) to find the best tolerated dose of belinostat when combined with CHOP and part B (dose expansion) is to determine the safety and tolerability in additional patients treated with the dose find in part A. Patients will receive belinostat plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone (CHOP).
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)